Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Prudence N. Gatt"'
Autor:
David Brown, Prudence N. Gatt, Graeme J. Stewart, Steve Vucic, Fiona C. McKay, Christopher Liddle, Samantha P L Law, Scott N. Byrne, Prue H. Hart, David R. Booth, Stephen D. Schibeci, Grant P Parnell
Publikováno v:
Genes and Immunity
Although genetic and epidemiological evidence indicates vitamin D insufficiency contributes to multiple sclerosis (MS), and serum levels of vitamin D increase on treatment with cholecalciferol, recent metanalyses indicate that this vitamin D form doe
Autor:
Clara P. Manrique, Fiona C. McKay, Prudence N. Gatt, Steve Vucic, Graeme J. Stewart, Nicole Fewings, Therese Burke, Monica A. I. Basuki, David R. Booth, Stephen D. Schibeci, Allan G. Kermode, Marzena J. Fabis-Pedrini, Dorothee Nickles, Anita Goldinger, Grant P Parnell, J. Edwards, Sergio E. Baranzini, Jacob L. McCauley
Publikováno v:
Journal of Autoimmunity. 78:57-69
Multiple Sclerosis (MS) is a neurological condition driven in part by immune cells from the peripheral circulation, the targets for current successful therapies. The autoimmune and MS risk gene ZMIZ1 is underexpressed in blood in people with MS. We s
Autor:
Prudence N. Gatt, Sergio E. Baranzini, Allan G. Kermode, Jacob L. McCauley, Fiona C. McKay, Nicole Fewings, David R. Booth, Dorothee Nickles, Stephen D. Schibeci, Graeme J. Stewart, Clara P. Manrique, Therese Burke, Anita Goldinger, J. Edwards, Steve Vucic, Grant P Parnell, Marzena J. Fabis-Pedrini, Monica A. I. Basuki
Publikováno v:
Data in Brief
Data in Brief, Vol 11, Iss C, Pp 364-370 (2017)
Data in Brief, Vol 11, Iss C, Pp 364-370 (2017)
The data presented in this article are related to the research article entitled “The autoimmune risk gene ZMIZ1 is a vitamin D responsived marker of a molecular phenotype of multiple sclerosis” Fewings et al. (2017) [1]. Here we identify the set
Autor:
Vilija Jokubaitis, Manuel Comabella, Vittorio Martinelli, Fiona C. McKay, Filippo Martinelli Boneschi, Malgorzata Krupa, Giuseppe Liberatore, Jeannette Lechner-Scott, Vijayaprakash Suppiah, G. Comi, Mark Slee, Allan G. Kermode, Xavier Montalban, C King, Max Moldovan, Bruce V. Taylor, Melissa Sorosina, Marzena J. Fabis-Pedrini, Sunny Malhotra, Sunil Mahurkar, Ferdinando Clarelli, Koen Vandenbroeck, Prudence N. Gatt, Alfredo Antigüedad
Publikováno v:
The Pharmacogenomics Journal. 17:312-318
Up to 50% of multiple sclerosis (MS) patients do not respond to interferon-beta (IFN-β) treatment and determination of response requires lengthy clinical follow-up of up to 2 years. Response predictive genetic markers would significantly improve dis
Autor:
Dorothee Nickles, Prudence N. Gatt, Steve Vucic, Michael Barnett, Mark Slee, David R. Booth, Stephen D. Schibeci, Malgorzata Krupa, Graeme J. Stewart, Sergio E. Baranzini, Grant P Parnell, Andrew P.D. Henderson, Fiona C. McKay, Marcel Batten
Publikováno v:
Clinical Immunology. 151(1):16-24
We have identified a marked over-representation of transcription factors controlling differentiation of T, B, myeloid and NK cells among the 110 MS genes now known to be associated with multiple sclerosis (MS). To test if the expression of these gene
Autor:
Mark Slee, Christopher Liddle, Steve Vucic, Fiona C. McKay, Jeannette Lechner-Scott, Malgorzata Krupa, Grant W. Montgomery, Grant P Parnell, Prudence N. Gatt, Simon Broadley, Joseph E. Powell, Graeme J. Stewart, Peter M. Visscher, David R. Booth, Stephen D. Schibeci
Publikováno v:
Multiple Sclerosis Journal. 20:675-685
Background: Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system which responds to therapies targeting circulating immune cells. Objective: Our aim was to test if the T-cell activation gene expression pattern (TCAGE) we
Autor:
Prudence N. Gatt, Ann M. Simpson, Zeger Debyser, Rik Gijsbers, Ming Q. Wei, Michelle R. Byrne, M. Anne Swan, Bronwyn A. O'Brien, Najah T. Nassif, Edwin Ch'ng, Binhai Ren
Publikováno v:
The Journal of Gene Medicine. 15:28-41
Background Type 1 diabetes (T1D) results from an autoimmune attack against the insulin-producing b-cells of the pancreas. The present study aimed to reverse T1D by gene therapy. Methods We used a novel surgical technique, which involves isolating the
Autor:
Therese Burke, Prudence N. Gatt, Monica A. I. Basuki, Steve Vucic, Fiona C. McKay, Allan G. Kermode, Nicole Fewings, Anita Goldinger, Marzena J. Fabis-Pedrini, Graeme J. Stewart, Joseph E. Powell, David R. Booth, Stephen D. Schibeci, Grant P Parnell
Publikováno v:
Clinical immunology (Orlando, Fla.). 163
Multiple Sclerosis (MS) is an autoimmune disease treated by therapies targeting peripheral blood cells. We previously identified that expression of two MS-risk genes, the transcription factors EOMES and TBX21 (ET), was low in blood from MS and stable
Autor:
Prudence N. Gatt, David R. Booth, Edwin Hoe, Stephen D. Schibeci, Grant P Parnell, Graeme J. Stewart, Fiona C. McKay
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 10, p e77508 (2013)
PLoS ONE, Vol 8, Iss 10, p e77508 (2013)
The IL7Rα gene is unequivocally associated with susceptibility to multiple sclerosis (MS). Haplotype 2 (Hap 2) confers protection from MS, and T cells and dendritic cells (DCs) of Hap 2 exhibit reduced splicing of exon 6, resulting in production of
Autor:
Con Yiannikas, Fabienne Brilot, Andrew Bleasel, Victor S.C. Fung, Prudence N. Gatt, John Parratt, Graeme J. Stewart, Russell C. Dale, Vera Merheb, David R. Booth, Stephen W. Reddel, Michael Barnett, Steve Vucic, Sudarshini Ramanathan, Mahtab Ghadiri, Andrew P.D. Henderson
Publikováno v:
Journal of Clinical Neuroscience. 21:2035
Autoantibodies such as those targeting aquaporin-4 are important biomarkers in central nervous system demyelination. We examined a cohort of patients with aquaporin-4 antibody seronegative neuromyelitis optica spectrum disorder (NMOSD) for serum anti